Have you heard about ovarian cancer? Known as a silent killer due to its subtle early symptoms, it can now be detected more effectively with the ROMA Algorithm. This innovative method combines CA125 and HE4 biomarkers for early risk assessment.

What is ROMA?
ROMA (Risk of Ovarian Malignancy Algorithm) uses an advanced algorithm to assess the risk of epithelial ovarian cancer. Unlike CA125 alone, it can differentiate between benign and malignant tumors. Using the CMIA method, ROMA quickly provides accurate results for risk evaluation.

Why is Early Detection Important?
Ovarian cancer is often diagnosed late due to vague symptoms. ROMA enables earlier detection, allowing timely medical interventions. For premenopausal women, high risk is indicated by ROMA ≥ 7.4%, and for postmenopausal women, it’s ROMA ≥ 25.3%.

Who Should Take This Test?
This test is recommended for women experiencing pelvic masses, those with a family history of ovarian cancer, or anyone monitoring reproductive health. Early detection prevents further complications and enables better outcomes.

Advantages of ROMA
Compared to traditional methods, ROMA provides greater specificity in distinguishing benign from malignant tumors, ensuring appropriate medical management. This makes ROMA an essential tool in ovarian cancer prevention.

Take charge of your reproductive health today with the ROMA test. Consult your doctor to learn more and take the first step toward early detection!

Reach out to SAPA PRAMITA at 0888 0305 7700 for any inquiries or further information. We're here to help!